UK Companies House feature
OBG HOLDING LIMITED
Cash
—
Latest balance sheet
Net assets
—
Equity attributable
Employees
0
Average over period
Profit before tax
—
Period ending 2024-12-31
Profile
- Company number
- 09943759
- Status
- Active
- Incorporation
- 2016-01-11
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
6-year trend · latest 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | |
| Net profit | £255,000 | £0 | -£3,173,066 | £0 | £80,000 | £120,000 | |
| Cash | — | — | — | — | — | — | |
| Total assets less current liabilities | — | — | — | — | — | — | |
| Net assets | — | — | — | — | — | — | |
| Equity | — | — | — | — | £40,744,127 | £40,744,127 | |
| Average employees | 0 | 0 | 0 | 0 | 0 | 0 | |
| Wages | £0 | £0 | £0 | £0 | £0 | £0 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- DSG Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- Ayrton Saunders and Company Ltd · 100% held · England and Wales · Manufacture of food additives
- Ayrton Saunders Limited · 100% held · England and Wales · Holder of intellectual property
- Baker Sillavan Limited · 100% held · England and Wales · Dormant
- British Chemical Products & Colours Limited · 100% held · England and Wales · Dormant
- Guangxi Talc Limited · 100% held · England and Wales · Dormant
- Haichen Talc Limited · 100% held · England and Wales · Dormant
- Hubron (International) Limited · 100% held · England and Wales · Sales and manufacture of carbon based masterbatch
- RBH Repacking Services Ltd · 100% held · England and Wales · Manufacture and sale of plastic packing products
- JM Loveridge Limited · 100% held · England and Wales · Non-trading
- OBG Pharmaceuticals Limited · 100% held · England and Wales · Group administration
- OBG Property Holding Limited · 100% held · England and Wales · Property holding company
- OBG Scientific Division Limited · 100% held · England and Wales · Holding company
- Pharmaserve (North West) Development Company Limited · 100% held · England and Wales · Development of specialist pharmaceutical products
- Pharmaserve (North West) Limited · 100% held · England and Wales · In administration
- Ransom Naturals Limited · 100% held · England and Wales · Manufacture and sales of flavourings and active pharmaceutical ingredients derived from plant extracts
- Richard Baker Harrison Limited · 100% held · England and Wales · Import and distribution of mineral and chemical products
- Western Minerals Limited · 100% held · England and Wales · Dormant
- Whitfield and Son Limited · 100% held · England and Wales · Dormant
- Whitfield International Limited · 100% held · England and Wales · Dormant
- Richard Baker Harrison (Ireland) Limited · 100% held · Ireland · Import and distribution of mineral and chemical products
- Ayrton Saunders (Ireland) Limited · 100% held · Ireland · Dormant
- Ayrton Saunders Inhalation Limited · 100% held · England and Wales · Development and commercialisation of inhalation products
- Ayrton Saunders (Development) Limited · 100% held · England and Wales · Development and commercialisation of inhalation products
- Ayrton Saunders, Inc. · 100% held · USA · Dissolved during the year
- OBG Consumer Scientific Limited · 100% held · England and Wales · Development of medical devices
- OBG Consumer Reg Scientific Limited · 100% held · England and Wales · Development of medical devices
- Dunwood Specialities Limited · 100% held · England and Wales · Non-trading
- Geniechem Limited · 100% held · England and Wales · Non-trading
- Geniechem Europe Limited · 100% held · The Netherlands · Dormant
- Faber & VanderEnde B.V · 100% held · The Netherlands · Wholesale of chemical products
- Faber & VanderEnde GmbH · 100% held · The Netherlands · Non-trading
- Nicovations New Zealand Limited · 100% held · New Zealand · Dormant
Significant events
- “On 28 February 2025, a subsidiary undertaking, OBG Pharmaceuticals Limited, executed a share charge in favour of HSBC UK Bank plc over its entire holding of 1 ordinary share in Richard Baker Harrison (Ireland) Limited, a fellow subsidiary undertaking and a private company limited by shares in Ireland with company number 640715. The charge constitutes a fixed charge and includes a negative pledge over the shares and associated rights, securing all present and future liabilities of the company to HSBC UK Bank plc under its existing banking arrangements. The charge does not affect the company's assets or liabilities as at the balance sheet date.”
- “On 20 March 2025, a subsidiary undertaking, Richard Baker Harrison Limited, entered into a deed of pledge of shares, whereby they pledged their shares in Faber & VanderEnde B.V to HSBC UK Bank plc as security for obligations under the invoice discounting facility. This arrangement provides HSBC UK Bank plc with a first ranking right of pledge over the secured assets as security which can be enforced in the event of default under the facility. The deed of pledge does not affect the company's operational control or shareholding structure as of the balance sheet date.”
- “On 1 April 2025, the company, OBG Holding Limited, passed a resolution to sub-divide its share capital. The existing 40 ordinary shares of £0.10 each were sub-divided into 400 ordinary shares of £0.01 each. The aggregate nominal value of the share capital remained unchanged at £4.00. Each ordinary share carries full rights in the company with respect to voting, dividends, and distributions, including on a winding up. The shares are not redeemable.”
- “On 25 July 2025, a subsidiary undertaking, Hubron (International) Limited, entered into a chattel mortgage agreement to finance items of plant and machinery with a value of £308,700. This event does not effect amounts recognised in the financial statements as of the balance sheet date.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DIDLICK, Philip James | Director | 2016-01-11 | Jun 1976 | British |
| O'BRIEN, Gerald Francis | Director | 2016-01-11 | Jan 1949 | British |
| O'BRIEN, Padraic Marc | Director | 2016-01-11 | Jun 1979 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROMILEY, Mark | Secretary | 2021-07-02 | 2025-03-07 |
| DIDLICK, Philip | Secretary | 2016-01-11 | 2021-07-02 |
| BROMILEY, Mark | Director | 2021-07-02 | 2025-03-07 |
| OBRIEN, Brigid Christina | Director | 2018-05-04 | 2025-05-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Padraic Marc O'Brien | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2025-04-01 | Active |
| Mr Gerald Francis O'Brien | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2025-04-01 |
| Mrs Brigid Christina Obrien | Individual | Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2022-04-28 |
Filing timeline
Last 20 of 45 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-12-18 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-12-17 | TM01 | officers | termination director company with name termination date |
| 2025-09-30 | AA | accounts | accounts with accounts type group |
| 2025-05-02 | SH02 | capital | capital alter shares subdivision |
| 2025-05-01 | RESOLUTIONS | resolution | resolution |
| 2025-04-29 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2025-04-28 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-04-28 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-03-11 | TM01 | officers | termination director company with name termination date |
| 2025-03-11 | TM02 | officers | termination secretary company with name termination date |
| 2025-03-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-30 | AA | accounts | accounts with accounts type group |
| 2023-10-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-29 | AA | accounts | accounts with accounts type group |
| 2022-10-20 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-10-20 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2022-09-30 | AA | accounts | accounts with accounts type group |
| 2022-01-11 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory